@article{NOVIANTI_ASMARIYAH_SURIYATI_WIRAHMI_2022, title={PHYSICAL EVALUATION OF RED GINGER EXTRACT (ZINGIBER OFFICINALE ROSC. VAR. RUBRUM) CREAM OF 10% AND 20% CONCENTRATION TO REDUCE LOW BACK PAIN FOR PREGNANT WOMEN IN SECOND AND THIRD OF TRIMESTERS}, volume={14}, url={https://journals.innovareacademics.in/index.php/ijap/article/view/44407}, DOI={10.22159/ijap.2022.v14s1.02}, abstractNote={<p><strong>Objective: </strong>The purpose of this study was evaluated the physical properties of the cream of red ginger extract <em>(Zingiber officinale Rosc var. Rubrum), </em>which is safe for pregnant women in helping pregnant women in the 2nd and 3rd trimesters to reduce low back pain.</p> <p><strong>Methods: </strong>The physical properties of red ginger extract (<em>Zingiber officinale </em>Rosc. var. Rubrum<em>) </em>cream was evaluated by using 2 activities, namely evaluation of creams consisting of organoleptic, pH, viscosity, spreadability and Homogeneity test, then continued with phytochemical screening, which consisted of an examination of alkaloids and examination of steroids.</p> <p><strong>Results: </strong>The evaluation results of making red ginger extract cream (<em>Zingiber officinale</em> Rosc. var. Rubrum) with a concentration of 10% and 20% me<em>et al. </em>l the requirements of the physical properties of the cream such as organoleptic test (smell, color, shape and texture are the same), pH test formula 1 (7.7980±0.13700), formula 2 (7.6060±0.9659), viscosity test formula 1 (22845.8440±12747.09092), formula 2 (39040.7480±206000.08235), dispersion test formula 1 (2.9400±0.25100-3.2200±0.41473), formula 2 (2.7600±0.23022-3.3100±0.17464) and homogeneity test on both formulas (homogeneous). Red ginger extract cream contains alkaloids from phytochemical screening results.</p> <p><strong>Conclusion: </strong>Red ginger extract cream (<em>Zingiber officinale </em>Rosc. var. Rubrum) with concentrations of 10% and 20% fulfills all the requirements for the physical properties of the cream and has the potential to be applied to pregnant women in the 2nd and 3rd trimesters who experience low back pain.</p>}, number={1}, journal={International Journal of Applied Pharmaceutics}, author={NOVIANTI and ASMARIYAH and SURIYATI and WIRAHMI, NORI}, year={2022}, month={Feb.}, pages={4–7} }